ATAD1 and Plasmodium falciparum malaria: Combined results from two studies showed no evidence of an association of MSP-1 block 1 responses with risk of symptomatic falciparum malaria (responders versus nonresponders RR 0.96, 95% CI 0.57–1.62, p = 0.88; Figure 4) [31],[43].